Roberto Tonelli, Riccardo Fantini, Giulia Bruzzi, Luca Tabbì, Andrea Cortegiani, Claudia Crimi, Lara Pisani, Antonio Moretti, Federico Guidotti, Simone Rizzato, Daniele Puggioni, Morgana Vermi, Matteo Tacconi, Gianluca Bellesia, Beatrice Ragnoli, Ivana Castaniere, Alessandro Marchioni, Enrico Clini
High flow nasal oxygen (HFNO) is recommended as a first-line respiratory support during acute hypoxic respiratory failure (AHRF) and represents a proportionate treatment option for patients with do not intubate (DNI) orders. The aim of the study is to assess the effect of HFNO on inspiratory effort as assessed by esophageal manometry in a population of DNI patients suffering from AHRF. Patients with AHRF and DNI orders admitted to Respiratory intermediate Care Unit between January 1st, 2018 and May 31st, 2023 to receive HFNO and subjected to esophageal manometry were enrolled...
December 29, 2023: Internal and Emergency Medicine